Antiproliferative and antimigratory effects of 3-(4-substituted benzyl)-5- isopropyl-5-phenylhydantoin derivatives in human breast cancer cells |
| |
Affiliation: | 1. Department of Biology and Ecology, Faculty of Science, University of Kragujevac, Kragujevac, Serbia;2. Department of Internal Medicine, Clinic for Hematology Clinical Center Kragujevac, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia;3. Department of Research and Development, Institute of Virology, Vaccines and Sera – TORLAK, Belgrade, Serbia;4. Department of Organic Chemistry, Faculty of Technology and Metallurgy, University of Belgrade, Belgrade, Serbia;5. Institute of Physiology and Biochemistry “Ivan Đaja”, Faculty of Biology, University of Belgrade, Belgrade, Serbia |
| |
Abstract: | In this study, a series of synthesized 3-(4-substituted benzyl)-5-isopropyl-5-phenylhydantoin derivatives as a potential antiproliferative and antimigratory agents were investigated. The possible antitumor mechanisms of investigated hydantoin derivatives were examined on human breast cancer cell line MDA-MB-231. The cells were treated with different concentrations of compounds (from 0.01 µM to 100 µM) during 24 h and 72 h. The proliferation index, nitric oxide production, apoptosis rate, and migration capacity were measured. The cell invasion potential was examined by measuring the level of MMP-9 and COX-2 gene expression. All tested compounds expressed antiproliferative activity and induced dose- and time-dependent increase in the level of nitrites. The investigated molecules significantly decreased cell survival rate, migration capacity and the expression levels of genes included in the process of tumor invasion. Obtained data suggest that the tested hydantoin derivatives express considerable antitumor activity by reducing cell division rate, elevating apoptosis level, and inhibiting the motility and invasiveness of breast cancer cells. The results obtained in this study indicate that investigated compounds express potential as a novel chemotherapeutic agents against breast cancer growth and progression. |
| |
Keywords: | Hydantoin derivatives Breast cancer cell line MDA-MB-231 Proliferation Apoptosis Cell motility Nitric oxide |
本文献已被 ScienceDirect 等数据库收录! |
|